Cypress Semiconductor Corporation (NASDAQ:CY) has recently announced it merger with another semiconductor company, Spansion Inc. (NYSE:CODE). This merger announcement has pushed the Cypress Semiconductor Corporation (NASDAQ:CY)’s stock price up by around 20% and post this announcement on Dec 1, this stock grew consistently and has achieved a growth of more than 30% in the last couple of weeks. Cypress Semiconductor Corporation (NASDAQ:CY) in last trading activity advanced 0.89% to close at $13.63. Company weekly performance is 4.69% while its quarterly performance stands at 35.08%. Cypress Semiconductor Corporation (NASDAQ:CY) is 0.52% away from its 52 week high.
Vertex Pharmaceuticals (NASDAQ:VRTX)’s hepatitis C drug called Incivek sales plummet after Sovaldi was approved. On last trading day Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) decreased -1.85% to close at $118.55. Its volatility for the week is 3.27% while volatility for the month is 3.14%. VRTX’s sales growth for past 5 years was 47.20% and its EPS growth for past 5 years was 9.50%. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) monthly performance is 1.60%.
Shares of Fortuna Silver Mines (NYSE:FSM) have received a consensus rating of “Buy” from the nine brokerages that are currently covering the stock. On last trading day Fortuna Silver Mines Inc. (NYSE:FSM) decreased -1.13% to close at $4.36. Its volatility for the week is 7.11% while volatility for the month is 7.29%. FSM’s EPS growth for past 5 years was 0.00%. Fortuna Silver Mines Inc. (NYSE:FSM) monthly performance is -2.68%.
Blyth, Inc. (NYSE: BTH), a direct to consumer company and leading designer and marketer of candles and accessories for the home and health, wellness and beauty products, household convenience items and personalized gifts sold through the direct selling and direct marketing channels, on 31 October 2014 reported sales and earnings for the third quarter of 2014. Net sales for the three months ended September 30, 2014 decreased approximately 6% to $90.8 million from $97.0 million for the comparable prior year period. Blyth, Inc. (NYSE:BTH) has 2.60% insider ownership while its institutional ownership stands at 47.10%. In last trading activity company’s stock closed at $8.93.
Streamline Health Solutions, Inc. (NASDAQ:STRM) a leading provider of transformational data-driven solutions to help healthcare providers reduce exposure to risk, enhance clinical, financial, and operational performance, and improve patient care, announced financial results for the third quarter of 2014, which ended October 31, 2014. Revenues for the three-month period ended October 31, 2014, increased approximately 2% to $6.8 million versus $6.7 million in the comparable period of fiscal 2013. Recurring revenues increased 11% in the third quarter over the same period a year earlier and are up 13% YTD over the comparable first nine months of fiscal 2013. On Friday shares of Streamline Health Solutions, Inc. (NASDAQ:STRM) closed at $3.80. Company’s sales growth for last 5 years was 11.80% and EPS growth for next 5 years is recorded as 15.00%.